KODIAK SCIENCES INC. Lease Obligation Incurred
KODIAK SCIENCES INC. (KOD) reported Lease Obligation Incurred of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Cash Flow
us-gaap:CapitalLeaseObligationsIncurred · last filed 2020-03-16
- KODIAK SCIENCES INC. lease obligation incurred for the quarter ending 2018-12-31 was $0.00.
- KODIAK SCIENCES INC. lease obligation incurred for the quarter ending 2017-12-31 was $0.00.
- KODIAK SCIENCES INC. lease obligation incurred for fiscal 2019 was $0.00.
- KODIAK SCIENCES INC. lease obligation incurred for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- KODIAK SCIENCES INC. lease obligation incurred for fiscal 2017 was $73.00K, a 70.33% decline from fiscal 2016.
- KODIAK SCIENCES INC. lease obligation incurred for fiscal 2016 was $246.00K.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 9 month | Lease Obligation Incurred 12 month |
|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-16 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 10-K · filed 2020-03-16 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-16 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $73.00K 10-K · filed 2020-03-16 | |
| 2017-09-30 | $73.00K 10-Q · filed 2018-11-16 | ||
| 2016-12-31 | $246.00K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |